Veracyte Inc (VCYT)
21.46
+0.66
(+3.17%)
USD |
NASDAQ |
May 28, 16:00
21.46
0.00 (0.00%)
After-Hours: 16:14
Veracyte Total Long Term Debt (Quarterly): 0.00 for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 1.187M |
June 30, 2022 | 1.133M |
March 31, 2022 | 1.079M |
December 31, 2021 | 1.127M |
September 30, 2021 | 1.075M |
June 30, 2021 | 0.917M |
March 31, 2021 | 0.863M |
December 31, 2020 | 0.81M |
September 30, 2020 | 0.756M |
June 30, 2020 | 0.801M |
March 31, 2020 | 0.748M |
December 31, 2019 | 0.694M |
September 30, 2019 | 0.639M |
June 30, 2019 | 0.585M |
March 31, 2019 | 12.85M |
December 31, 2018 | 25.28M |
September 30, 2018 | 25.19M |
June 30, 2018 | 25.10M |
Date | Value |
---|---|
March 31, 2018 | 25.02M |
December 31, 2017 | 24.94M |
September 30, 2017 | 25.00M |
June 30, 2017 | 24.97M |
March 31, 2017 | 24.94M |
December 31, 2016 | 24.92M |
September 30, 2016 | 24.89M |
June 30, 2016 | 24.67M |
March 31, 2016 | 24.45M |
December 31, 2015 | 4.99M |
September 30, 2015 | 5.002M |
June 30, 2015 | 4.975M |
March 31, 2015 | 4.949M |
December 31, 2014 | 4.923M |
September 30, 2014 | 5.007M |
June 30, 2014 | 4.971M |
March 31, 2014 | 4.934M |
December 31, 2013 | 4.899M |
September 30, 2013 | 4.863M |
June 30, 2013 | 4.826M |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2022
1.187M
Maximum
Sep 2022
0.6207M
Average
0.752M
Median
Total Long Term Debt (Quarterly) Benchmarks
Fonar Corp | 0.126M |
XWELL Inc | 0.00 |
ProPhase Labs Inc | 12.68M |
Applied DNA Sciences Inc | 0.00 |
OncoCyte Corp | 0.00 |